This study is designed with the main aim to investigate the effect of
Apium Graveolence and Trachyspermum Copticum traditional product on
clinical symptoms of patients with Functional Dyspepsia, and will be
performed as a randomized (Blocked randomization), double blind, placebo-control trial at one
medical center in Iran; the studied groups include a group taking the
Apium Graveolence and Trachyspermum Copticum traditional product, a
group taking Omeprazole capsules, and a placebo group, each of which
consisting of 50 FD patients, based on the ROME3 criteria.
The main inclusion criteria is an age of 18 to 60 years old, whereas
the main exclusion criteria is use of chemical and herbal drugs of
functional dyspepsia; four weeks of administration of the drug or
placebo will be conducted and a subsequent two-month follow-up
observation of the primary and the secondary outcomes will be
performed based on ranking the severity and frequency of
gastrointestinal symptoms as well as the quality of life. Primary
outcome time point will be at the baseline, 2nd, 4th, and 8th week,
while the quality of life will be measured at the baseline, 4th
and 8th week.